Exagen Inc. - (XGN) share price
Exagen Inc. - (NASDAQ:XGN) last traded at $5.81, down 23.55% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.14B and a 52-week range of $2.59 to $10.27.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $5.81 |
| 1-day move | -23.55% |
| 52-week range | $2.59 - $10.27 |
| Market cap | $0.14B |
| From 52-week high | -43.40% |
| Volume vs average | 3.7x |
| Falling Shares risk score | 71/100 (CRITICAL) |
| Country | United States |
Frequently asked questions
Why is Exagen Inc. - falling today?
Exagen Inc. - (NASDAQ:XGN) is down 23.55% at its latest quote and trades 43.4% below its 52-week high, on volume 3.7x its average. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Exagen Inc. - share price today?
Exagen Inc. - (NASDAQ:XGN) last traded at $5.81, a -23.55% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Exagen Inc. -?
Exagen Inc. -'s 52-week low is $2.59 and its 52-week high is $10.27; the shares trade 43.4% below the high.
What is the market cap of Exagen Inc. -?
Exagen Inc. - has a market capitalisation of about $0.14B at the latest price.
What are the risks of investing in Exagen Inc. -?
Falling Shares Intelligence rates Exagen Inc. - 71/100 (CRITICAL) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com